Balasa Dinverno & Foltz LLC Gsk PLC Transaction History

Balasa Dinverno & Foltz LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$37.87 - $43.58 $253,085 - $291,245	-6,683 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$32.47 - $48.83 $7,597 - $11,426	-234 Reduced 3.38%	6,683 $253,000
Q4 2019 Jan 22, 2020	BUY	$42.0 - $48.25 $1,764 - $2,026	42 Added 0.61%	6,917 $325,000
Q3 2019 Nov 06, 2019	BUY	$40.46 - $43.52 $3,074 - $3,307	76 Added 1.12%	6,875 $293,000
Q2 2019 Aug 07, 2019	BUY	$39.4 - $42.7 $2,048 - $2,220	52 Added 0.77%	6,799 $272,000
Q1 2019 May 10, 2019	SELL	$38.57 - $42.69 $4,396 - $4,866	-114 Reduced 1.66%	6,747 $282,000
Q1 2018 Apr 23, 2018	SELL	$36.18 - $40.15 $2,930 - $3,252	-81 Reduced 1.17%	6,861 $268,000
Q3 2017 Oct 18, 2017	BUY	$39.44 - $41.55 $273,792 - $288,440	6,942	6,942 $282,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $82.8B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.